52P Real-world Versus Clinical Trial Outcomes of Pembrolizumab Plus Chemotherapy in Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer

M. Verschueren,V. Kruik,B. Peters,L. Bloem,A. R. Bijsmans,T. Egberts,E. van de Garde

Journal of thoracic oncology（2023）

Cited 0|Views8

No score

Abstract

For many systemic treatments in oncology, a divergence between efficacy in clinical trials versus effectiveness in clinical practice has been observed. The present study investigated the real-world outcomes for pembrolizumab plus chemotherapy in patients with stage IV non-squamous non-small cell lung cancer (NSCLC) and compared these with the results of the KEYNOTE-189 trial.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined